This website uses cookies to improve your experience. Continue if you are OK with this or read more in our privacy policy. 

US court rules on reverse payment patent settlement


The US Court of Appeals for the Second Circuit ruled on April 29 that a so-called ‘reverse payment patent settlement’ between pharmaceutical company Bayer and three generic drugs companies did not violate US antitrust laws.

US, Court of Appeals, Bayer, reverse, payment, patents


Payment types accepted